Table 2.
Clinicopathological characteristics of TNBC cohort YTMA-341
| Characteristic | Categories | N (%) | Total (%) |
|---|---|---|---|
| Age | 54 (29-84) | 37 (24.5) | |
| Stage | I | 43 (28.5) | 118 (78.1) |
| II | 57 (37.7) | ||
| III | 14 (9.3) | ||
| IV | 4 (2.6) | ||
| Neoadjuvant chemotherapy | Yes | 9 (6.0) | 126 (83.5) |
| No | 117 (77.5) | ||
| Surgery | Yes | 133 (88.1) | 134 (88.8) |
| No | 1 (0.7) | ||
| Adjuvant chemotherapy | Yes | 82 (54.3) | 109 (72.2) |
| No | 27 (17.9) | ||
| Postsurgical radiotherapy | Yes | 65 (43.0) | 111 (73.5) |
| No | 46 (30.5) | ||
| Disease recurrence | Yes | 27 (17.9) | 119 (78.8) |
| No | 92 60.9) | ||
| Death (all cause) | Yes | 43 (28.5) | 137 (90.8) |
| No | 94 (62.3) |